RBC Europe’s Novartis NVS Stock Holding History

RBC Europe’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$217K	Hold	2,570	–	–	0.01%	199
2022 Q1	$226K	Hold	2,570	–	–	0.01%	212
2021 Q4	$225K	Sell	2,570 -200	-7%	-$16.6K	0.01%	217
2021 Q3	$227K	Hold	2,770	–	–	0.01%	281
2021 Q2	$253K	Buy	2,770 +270	+11%	+$24K	0.01%	283
2021 Q1	$214K	Hold	2,500	–	–	0.01%	286
2020 Q4	$236K	Hold	2,500	–	–	0.01%	256
2020 Q3	$217K	Hold	2,500	–	–	0.01%	246
2020 Q2	$218K	Hold	2,500	–	–	0.02%	229
2020 Q1	$206K	Hold	2,500	–	–	0.02%	206
2019 Q4	$237K	Hold	2,500	–	–	0.02%	230
2019 Q3	$217K	Buy	2,500 +400	+19%	+$35.9K	0.02%	237
2019 Q2	$192K	Sell	2,100 -244	-10%	-$20.7K	0.02%	252
2019 Q1	$202K	Sell	2,344 -167	-7%	-$13.4K	0.02%	239
2018 Q4	$193K	Sell	2,511 -781	-24%	-$60.8K	0.03%	225
2018 Q3	$254K	Hold	3,292	–	–	0.03%	215
2018 Q2	$223K	Hold	3,292	–	–	0.03%	233
2018 Q1	$239K	Hold	3,292	–	–	0.03%	222
2017 Q4	$248K	Sell	3,292 -397	-11%	-$30K	0.03%	226
2017 Q3	$284K	Buy	+3,689	New	+$279K	0.04%	206

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

RBC Europe's NVS Position: Q2 2022 in Review

RBC Europe held its Novartis (NVS) position steady in Q2 2022 at 2,570 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #199.

RBC Europe first reported a position in NVS in Q3 2017 and has held it in 20 quarters since. The position peaked at $284K in Q3 2017. 1,141 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

RBC Europe held 2,570 shares of Novartis worth $217K as of Q2 2022.
RBC Europe left its Novartis share count unchanged in Q2 2022.
Novartis made up 0.01% of RBC Europe's portfolio in Q2 2022, its #199 holding.
RBC Europe first reported a position in Novartis in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Novartis position peaked at $284K in Q3 2017.
1,141 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.